Startups

Principal Scientist, Translational Medicine

Denali Therapeutics · South San Francisco · On-site

← All jobs
About Denali Therapeutics

Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases. Backed by GV.

About the role

We invite you to consider an opportunity with Denali to help achieve our goal of delivering meaningful therapeutics to patients.

What they're looking for

  • PhD in a relevant scientific discipline (e.g., biochemistry, neurobiology, molecular biology, pharmacology) with typically 10+ years of post-training industry and/or academic experience
  • Demonstrated expertise in developing, executing, and interpreting complex biomarker assays in a clinical study setting
  • Experience contributing to regulatory submissions (e.g., BLA, NDA, IND), particularly biomarker-related sections and health authority interactions
  • Record of high-quality publications and/or public presentations in rare disease, translational research, or biomarkers
  • Strong oral, written, and presentation communication skills across scientific and cross-functional audiences
More about this role

Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.

We invite you to consider an opportunity with Denali to help achieve our goal of delivering meaningful therapeutics to patients.

This role partners with experts across Discovery and Development to build biomarker strategies that enable biomarker-driven clinical development plans supporting dose selection, biomarker proof-of-concept, and deep patient phenotyping in rare, genetically defined, and/or neurodegenerative diseases. It brings broad drug development and regulatory expertise together with biomarker strategy leadership to advance large-molecule therapeutics through the clinical pipeline and approval.

Key Accountabilities / Core Job...

Read the full posting on Denali Therapeutics's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.